The impact of culture isolation of Aspergillus species:: A hospital-based survey of aspergillosis

被引:327
作者
Perfect, JR
Cox, GM
Lee, JY
Kauffman, CA
de Repentigny, L
Chapman, SW
Morrison, VA
Pappas, P
Hiemenz, JW
Stevens, DA
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Vet Affairs Med Ctr, Ann Arbor, MI USA
[5] Univ Montreal, Montreal, PQ H3C 3J7, Canada
[6] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
[7] Vet Affairs Med Ctr, Minneapolis, MN USA
[8] Albany Med Ctr, Albany, NY USA
[9] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA
[10] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
10.1086/323900
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The term "aspergillosis" comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on the diagnosis, risk factors, management, and outcome associated with these diseases. Most Aspergillus culture isolates from nonsterile body sites do not represent disease. However, for high-risk patients, such as allogeneic bone marrow transplant recipients (60%), persons with hematologic cancer (50%), and those with signs of neutropenia (60%) or malnutrition (30%), a positive culture result is associated with invasive disease. When such risk factors as human immunodeficiency virus infection (20%), solid-organ transplantation (20%), corticosteroid use (20%), or an underlying pulmonary disease (10%) are associated with a positive culture result, clinical judgment and better diagnostic tests are necessary. The management of invasive aspergillosis remains suboptimal: only 38% of patients are alive 3 months after diagnosis. Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes.
引用
收藏
页码:1824 / 1833
页数:10
相关论文
共 82 条
  • [1] ARNOW PM, 1978, AM REV RESPIR DIS, V118, P49
  • [2] ENDEMIC AND EPIDEMIC ASPERGILLOSIS ASSOCIATED WITH IN-HOSPITAL REPLICATION OF ASPERGILLUS ORGANISMS
    ARNOW, PM
    SADIGH, M
    COSTAS, C
    WEIL, D
    CHUDY, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (05) : 998 - 1002
  • [3] BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
  • [4] 10 YEAR REVIEW OF INVASIVE ASPERGILLOSIS DETECTED AT NECROPSY
    BOON, AP
    OBRIEN, D
    ADAMS, DH
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (06) : 452 - 454
  • [5] Incidence and significance of Aspergillus cultures following liver and kidney transplantation
    Brown, RS
    Lake, JR
    Katzman, BA
    Ascher, NL
    Somberg, KA
    Emond, JC
    Roberts, JP
    [J]. TRANSPLANTATION, 1996, 61 (04) : 666 - 669
  • [6] Aspergillus airway colonization and invasive disease after lung transplantation
    Cahill, BC
    Hibbs, JR
    Savik, K
    Juni, BA
    Dosland, BM
    EdinStibbe, C
    Hertz, MI
    [J]. CHEST, 1997, 112 (05) : 1160 - 1164
  • [7] Aspergillus: An increasing problem in tertiary care hospitals?
    Chandrasekar, PH
    Alangaden, G
    Manavathu, E
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (06) : 984 - 985
  • [8] Treatment strategies for Aspergillus infections
    Chiller, TM
    Stevens, DA
    [J]. DRUG RESISTANCE UPDATES, 2000, 3 (02) : 89 - 97
  • [9] EPIDEMIOLOGY OF INVASIVE ASPERGILLOSIS IN EUROPEAN CANCER CENTERS
    COHEN, J
    DENNING, DW
    VIVIANI, MA
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (05) : 392 - 393
  • [10] Burden of aspergillosis-related hospitalizations in the United States
    Dasbach, EJ
    Davies, GM
    Teutsch, SM
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) : 1524 - 1528